Pharmacists propose class action lawsuit against Shoppers Drug Mart over “risk of causing patient harm”
Franchise owners claim they were placed in situations that caused an “irredeemable conflict of interest” after the company Loblaws acquired Shoppers Drug Mart in 2014. 

Alexa Posa

April 19, 2024

Previous and current franchise owners proposed a class action lawsuit against Shoppers Drug Mart for “risks to patient safety” and “risk of causing patient harm.”

Pharmacists propose class action lawsuit against Shoppers Drug Mart over “risk of causing patient harm”

The uncertified lawsuit was filed on April 11 at the Ontario Superior Court of Justice by Toronto-based law firm Ricketts Harris LLP.

The franchise owners claim they were placed in situations that caused an “irredeemable conflict of interest” after the company Loblaws acquired Shoppers Drug Mart in 2014. 

Loblaws allegedly created “risks to patient safety and pose a significant risk of causing patient harm,” according to a statement of claim

The practices named in the suit include medication reviews, along with vaccinations, illness diagnoses, and prescriptions. 

Pharmacist terminated for speaking out 

The claim additionally states that Shoppers Drug Mart has terminated contracts with pharmacists who questioned the alleged unsafe practices and “breached key obligations.” 

Sivajana Sivapalan, a pharmacist leading the lawsuit, said he was terminated without reason from Shoppers Drug Mart in 2023 after expressing concerns in regards to their business decisions. 

Sivapalan has been running their pharmacy for 12 years, working in Beamsville, Ontario, since 2011. 

Franchise owners say that despite communicating concern, Loblaws has taken “little to no action” to address the issues.

The Ontario College of Pharmacists

After a meeting with the Ontario College of Pharmacists (OCP) on March 25, they announced a “zero tolerance” for business practices that will prevent the “ability to deliver effective care” to patients. 

The OCP claimed to hear from “thousands” of pharmacists concerning unsafe practices involving patients and stated in a news release they found “inappropriate pressure” to conduct medication reviews “deeply troubling.”

“The College will consider every tool available to us to address those concerns,” they added.

Loblaws has spoken out regarding the proposed suit, saying the case has “no merit whatsoever” and the company will “vigorously defend” itself.

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

“Last time I was here, I think I said government spending on goods and services was forecast to grow at about two and a quarter. That has now moved up to two and three quarters. That is somewhat above two per cent, so, yeah, that is not helpful…”

Keean Bexte

May 2, 2024

Trending News

Liberal Premier says of carbon tax: “It doesn’t make sense from a logical perspective.”

TCS Wire

May 1, 2024

Trending News

“The bill that I’m going to sign today is going to say basically take your fake lab-grown meat elsewhere. We’re not doing that in the state of Florida,” DeSantis said.

TCS Wire

May 1, 2024

Trending News

Conservatives have labeled Mark Carney as “Carbon Tax Carney,” accusing him of profiting financially from the very policies he promotes.

Mike Campbell

April 30, 2024

Trending News

Viral confrontation highlights a growing concern among many that the shift towards digital-only transactions could lead to increased surveillance and control.

Mike Campbell

April 30, 2024

Trending News

The idea of expanding railways within Alberta has been floated for over a decade and a half, but Premier Danielle Smith says the time to act on a comprehensive railway plan is now, especially given the massive and historic migration to the province.

TCS Wire

April 30, 2024

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.